Cargando…

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway

In previous studies, miR-29s showed tumor suppressor properties against lung cancer, which improved the survival of patients upon the administration of chemotherapy via an unknown mechanism. Here, we investigated the regulatory effects of miR-29s on the cisplatin resistance of NSCLC cells. The expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dian-min, Tang, Bu-fu, Li, Zhen-xiang, Guo, Hong-bo, Cheng, Jin-ling, Song, Ping-ping, Zhao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964122/ https://www.ncbi.nlm.nih.gov/pubmed/29789623 http://dx.doi.org/10.1038/s41598-018-26381-w

Ejemplares similares

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway
por: Feng, Weifeng, et al.
Publicado: (2022)

Effect of miR‑29a‑3p in exosomes on glioma cells by regulating the PI3K/AKT/HIF‑1α pathway
por: Liu, Zeqiang, et al.
Publicado: (2023)

Lanthanum Chloride Sensitizes Cisplatin Resistance of Ovarian Cancer Cells via PI3K/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
por: Yang, Ying, et al.
Publicado: (2021)

miR-29b enhances the proliferation and migration of bone marrow mesenchymal stem cells in rats with castration-induced osteoporosis through the PI3K/AKT and TGF-β/Smad signaling pathways
por: Wang, Yuhui, et al.
Publicado: (2020)

[Retracted] miR‑29b enhances the proliferation and migration of bone marrow mesenchymal stem cells in rats with castration‑induced osteoporosis through the PI3K/AKT and TGF‑β/Smad signaling pathways
por: Wang, Yuhui, et al.
Publicado: (2022)

miR-155 Regulates the Proliferation of Glioma Cells Through PI3K/AKT Signaling
por: Wu, Dahao, et al.
Publicado: (2020)

miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
por: Liu, Jiangang, et al.
Publicado: (2018)

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
por: YAN, LI-XU, et al.
Publicado: (2015)

Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway
por: Liu, Ying, et al.
Publicado: (2019)

miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines
por: kalhori, Mohammad Reza, et al.
Publicado: (2020)

miR-10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway
por: Huang, Tonghai, et al.
Publicado: (2020)

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
por: Yang, Wu, et al.
Publicado: (2020)

MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells
por: Tsitoura, Eliza, et al.
Publicado: (2016)

Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway
por: Liu, Gang, et al.
Publicado: (2019)

c-Myb protects cochlear hair cells from cisplatin-induced damage via the PI3K/Akt signaling pathway
por: Bu, Chuan, et al.
Publicado: (2022)

Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT
por: Zheng, Zhiming, et al.
Publicado: (2017)

Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway
por: ZHANG, HONG-BO, et al.
Publicado: (2013)

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38
por: Gohr, Katharina, et al.
Publicado: (2017)

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
por: NAVAEI, ZAHRA NASRPOUR, et al.
Publicado: (2022)

Up-regulation of PUM1 by miR-218-5p promotes colorectal tumor-initiating cell properties and tumorigenesis by regulating the PI3K/AKT axis
por: Liu, Qi-Zhi, et al.
Publicado: (2023)

Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6
por: Xi, Zhuo, et al.
Publicado: (2017)

miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway
por: Jiang, Lili, et al.
Publicado: (2015)

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017)

Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway
por: Lu, Chunya, et al.
Publicado: (2018)

miR-29 promotes the proliferation of cultured rat neural stem/progenitor cells via the PTEN/AKT signaling pathway
por: Gao, Yunan, et al.
Publicado: (2019)

miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development
por: Wei, W, et al.
Publicado: (2013)

miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1
por: Jiang, Baoen, et al.
Publicado: (2021)

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN
por: Lin, Hui, et al.
Publicado: (2018)

Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway
por: Wang, Yan, et al.
Publicado: (2013)

miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020)

miR-431 regulates granulosa cell function through the IRS2/PI3K/AKT signaling pathway
por: YANG, Lei, et al.
Publicado: (2020)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN
por: Du, Wei, et al.
Publicado: (2019)

Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR‐9 pathway
por: Bing, Weidong, et al.
Publicado: (2016)

MiR-330-Mediated Regulation of SH3GL2 Expression Enhances Malignant Behaviors of Glioblastoma Stem Cells by Activating ERK and PI3K/AKT Signaling Pathways
por: Yao, Yilong, et al.
Publicado: (2014)

MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling
por: Liu, Yongjie, et al.
Publicado: (2018)

Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT
por: Zhou, Hong-Hao, et al.
Publicado: (2016)

Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway
por: Lin, Qiongyan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_00fu0u0p7fj0qi5sumkctfevln